These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 20947480)

  • 1. Targeting cytoskeleton reorganisation as antimetastatic treatment.
    Quintela-Fandino M; González-Martín A; Colomer R
    Clin Transl Oncol; 2010 Oct; 12(10):662-9. PubMed ID: 20947480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halting metastasis through CXCR4 inhibition.
    Ramsey DM; McAlpine SR
    Bioorg Med Chem Lett; 2013 Jan; 23(1):20-5. PubMed ID: 23211868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.
    Gandalovičová A; Rosel D; Fernandes M; Veselý P; Heneberg P; Čermák V; Petruželka L; Kumar S; Sanz-Moreno V; Brábek J
    Trends Cancer; 2017 Jun; 3(6):391-406. PubMed ID: 28670628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
    Schwock J; Dhani N; Hedley DW
    Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis: a therapeutic target for cancer.
    Steeg PS; Theodorescu D
    Nat Clin Pract Oncol; 2008 Apr; 5(4):206-19. PubMed ID: 18253104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents.
    Fouani L; Menezes SV; Paulson M; Richardson DR; Kovacevic Z
    Pharmacol Res; 2017 Jan; 115():275-287. PubMed ID: 27940016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combretastatin A-4 derived imidazoles show cytotoxic, antivascular, and antimetastatic effects based on cytoskeletal reorganisation.
    Mahal K; Biersack B; Caysa H; Schobert R; Mueller T
    Invest New Drugs; 2015 Jun; 33(3):541-54. PubMed ID: 25678082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-invasive/anti-metastasis strategies: new roads, new tools and new hopes.
    Dollé L; Depypere HT; Bracke ME
    Curr Cancer Drug Targets; 2006 Dec; 6(8):729-51. PubMed ID: 17168676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future approaches for the therapeutic targeting of metastasis (review).
    Germanov E; Berman JN; Guernsey DL
    Int J Mol Med; 2006 Dec; 18(6):1025-36. PubMed ID: 17089005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor metastasis: molecular insights and evolving paradigms.
    Valastyan S; Weinberg RA
    Cell; 2011 Oct; 147(2):275-92. PubMed ID: 22000009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-metastatics: an overview of drug candidates in current pipelines.
    Schaap-Nutt A; Thyssen DA; Drell DW; Entschladen F
    Curr Pharm Des; 2014; 20(42):6522-8. PubMed ID: 25341929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer cell integrins using gold nanorods in photothermal therapy inhibits migration through affecting cytoskeletal proteins.
    Ali MRK; Wu Y; Tang Y; Xiao H; Chen K; Han T; Fang N; Wu R; El-Sayed MA
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5655-E5663. PubMed ID: 28652358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the Structure-Activity Relationship of Natural and Synthetic Antimetastatic Compounds.
    Liew SK; Malagobadan S; Arshad NM; Nagoor NH
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium and cancer metastasis: Perspectives for antimetastatic therapy.
    Blazejczyk A; Papiernik D; Porshneva K; Sadowska J; Wietrzyk J
    Pharmacol Rep; 2015 Aug; 67(4):711-8. PubMed ID: 26321272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cytoskeletal dynamics and nonlinear rheology with metastatic ability in cancer cell lines.
    Coughlin MF; Fredberg JJ
    Phys Biol; 2013 Dec; 10(6):065001. PubMed ID: 24304722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis awakening: the challenges of targeting minimal residual cancer.
    Polzer B; Klein CA
    Nat Med; 2013 Mar; 19(3):274-5. PubMed ID: 23467237
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental and clinical effects of anticoagulants on cancer progression.
    Van Noorden CJ; van Sluis GL; Spek CA
    Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.
    Iiizumi M; Liu W; Pai SK; Furuta E; Watabe K
    Biochim Biophys Acta; 2008 Dec; 1786(2):87-104. PubMed ID: 18692117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.